Your browser doesn't support javascript.
loading
The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.
Biernacka, J M; Sangkuhl, K; Jenkins, G; Whaley, R M; Barman, P; Batzler, A; Altman, R B; Arolt, V; Brockmöller, J; Chen, C H; Domschke, K; Hall-Flavin, D K; Hong, C J; Illi, A; Ji, Y; Kampman, O; Kinoshita, T; Leinonen, E; Liou, Y J; Mushiroda, T; Nonen, S; Skime, M K; Wang, L; Baune, B T; Kato, M; Liu, Y L; Praphanphoj, V; Stingl, J C; Tsai, S J; Kubo, M; Klein, T E; Weinshilboum, R.
Afiliação
  • Biernacka JM; 1] Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA [2] Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Sangkuhl K; Department of Genetics, Stanford University, Stanford, CA, USA.
  • Jenkins G; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Whaley RM; Department of Genetics, Stanford University, Stanford, CA, USA.
  • Barman P; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Batzler A; Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Altman RB; 1] Department of Genetics, Stanford University, Stanford, CA, USA [2] Department of Bioengineering, Stanford University, Stanford, CA, USA.
  • Arolt V; Department of Psychiatry and Psychotherapy, University of Muenster, Muenster, Germany.
  • Brockmöller J; Department of Clinical Pharmacology, University Göttingen, Göttingen, Germany.
  • Chen CH; Department of Psychiatry, Taipei Medical University-Shuangho Hospital, New Taipei City, Taiwan.
  • Domschke K; Department of Psychiatry, Psychosomatics and Psychotherapy, University of Wuerzburg, Wuerzburg, Germany.
  • Hall-Flavin DK; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
  • Hong CJ; 1] Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan [2] Division of Psychiatry, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Illi A; Department of Psychiatry, School of Medicine, University of Tampere, Tampere, Finland.
  • Ji Y; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
  • Kampman O; 1] Department of Psychiatry, School of Medicine, University of Tampere, Tampere, Finland [2] Department of Psychiatry, Seinäjoki Hospital District, Seinäjoki, Finland.
  • Kinoshita T; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan.
  • Leinonen E; 1] Department of Psychiatry, School of Medicine, University of Tampere, Tampere, Finland [2] Department of Psychiatry, Tampere University Hospital, Tampere, Finland.
  • Liou YJ; 1] Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan [2] Division of Psychiatry, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Mushiroda T; RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.
  • Nonen S; Department of Pharmacy, Hyogo University of Health Sciences, Hyogo, Japan.
  • Skime MK; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
  • Wang L; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
  • Baune BT; Department of Psychiatry, University of Adelaide, Adelaide, SA, Australia.
  • Kato M; Department of Neuropsychiatry, Kansai Medical University, Osaka, Japan.
  • Liu YL; Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli, Taiwan.
  • Praphanphoj V; Center for Medical Genetics Research, Rajanukul Institute, Department of Mental Health, Ministry of Public Health Bangkok, Bangkok, Thailand.
  • Stingl JC; Research Division Federal Institute for Drugs and Medical Devices, Bonn, Germany.
  • Tsai SJ; 1] Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan [2] Division of Psychiatry, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
  • Kubo M; RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.
  • Klein TE; Department of Genetics, Stanford University, Stanford, CA, USA.
  • Weinshilboum R; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.
Transl Psychiatry ; 5: e553, 2015 04 21.
Article em En | MEDLINE | ID: mdl-25897834

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores Seletivos de Recaptação de Serotonina / Transtorno Depressivo Maior / Antidepressivos Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Transl Psychiatry Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores Seletivos de Recaptação de Serotonina / Transtorno Depressivo Maior / Antidepressivos Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Transl Psychiatry Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos